Abstract
Introduction: Since December 2019, novel coronavirus (COVID-19) infection has been identified as the cause of an outbreak of respiratory illness in Wuhan, China. The classic presentation of COVID-19 infection was described as fever, myalgia, cough, and fatigue. Whether coronavirus can directly attack the endocrine glands is unclear. Objective: Post-viral subacute thyroiditis (SAT, de Quervain thyroiditis) has been reported following other viral infection. A limited number of SAT after COVID-19 infection have been reported up to now. Methods: Here, we reported 6 patients with SAT and positive COVID-19 serology tests. Demographic, clinical, biochemical, and imaging data were presented. Results: In this study, 6 patients (4 women and 2 men) with clinician manifestations and physical examination in favor of SAT were described. Cervical ultrasonography showed bilateral hypoechoic areas in the thyroid gland which was suggestive of SAT. Elevated C-reactive protein, erythrocyte sedimentation rate, free thyroxine, free tri-iodothyronine, and undetectable thyrotropin were found in laboratory evaluations. Both IgM and IgG were positive for COVID-19 infection, but the PCR tests were negative in all patients. Patients had history of working in a COVID center and/or family member hospitalized due to COVID-19 pneumonia. Patients were followed up for 1 month and were treated effectively with steroids. Conclusion: This report may help physicians to identify lesser-known manifestations and complications of COVID-19. Early diagnosis of COVID-19 infection results in the prevention of further transmission.
In early December 2019, novel coronavirus (COVID-19) infection has been identified as the cause of an outbreak of respiratory illness in Wuhan, China [1]. The World Health Organization declared COVID-19 outbreak as a pandemic as of March 11, 2020 [2].
The classic presentations of COVID-19 infection were described as fever, myalgia, cough, fatigue, and gastrointestinal symptoms such as nausea, vomiting, diarrhea, and abdominal pain [3]. However, different and lesser-known clinical manifestations have also been reported [4-6]. Whether coronavirus can directly attack the endocrine glands is unclear. Post-viral subacute thyroiditis (SAT, de Quervain thyroiditis) has been reported during outbreaks of other viral infection [7, 8]. Here, we report 6 patients with SAT and positive COVID-19 serology test.
During COVID-19 pandemic 6 patients (4 women and 2 men) were referred to our hospital with same clinical scenarios including fever (more than 38°C), fatigue, palpitations, and anterior neck pain, data of which are presented in Table 1. Patients’ physical examination revealed markedly painful, tender, and slightly enlarged thyroid gland. With suspicion to SAT, cervical ultrasonography was performed for each patient. The ultrasonographies showed bilateral hypoechoic areas in thyroid gland which was suggestive of SAT. Laboratory results showed mildly elevated free thyroxine and free tri-iodothyronine with undetectable thyrotropin. C-reactive protein levels were also slightly elevated, and in all patients, erythrocyte sedimentation rate was more than 60 mm/h.
Demographic, clinical, and biochemical data in patients with SAT following COVID-19 infection
Some patients reported brief, nonspecific symptoms such as low-grade fever and myalgia in the past month prior to their acute presentations, but the symptoms have resolved spontaneously. Two of the patients were nurses at COVID-19 centers. The other 2 had a history of traveling to high-prevalence coronavirus areas. Also 3 out of 6 patients had a history of family members’ hospitalization due to COVID-19 pneumonia within 2 weeks. Therefore, PCR and immunoglobulin (IgM and IgG) tests were requested to evaluate COVID-19 infection. The PCR tests were negative in all patients but both IgM and IgG were positive for COVID-19 infection. Serology tests were performed using SARS-CoV-2 (COVID-19) IgG and IgM ELISA kits (BL International GmbH, Flughafenstraße 52a, DE–22335 Hamburg, Germany; IgM REF: 30176470; IgG REF: 30177447).
Their chest computed tomography scans were unremarkable. Patients were treated with prednisolone 25 mg/day for 10 days and were tapered in 4 weeks. After 1 week, the symptoms disappeared and after 1 month thyroid function tests were normal.
To our current knowledge, only few studies in the English-language articles reported SAT in COVID-19 patients [9-12]. The etiology and pathogenesis of SAT have not been completely understood. SAT can be secondary to viral upper respiratory tract infection in genetically predisposed individuals. Several viruses have been identified as the cause of SAT including, mumps virus, cytomegalovirus, enterovirus, and coxsackie virus [13]. In this study, the screening serology testing for respiratory viral panel, viral hepatitis, mumps virus, cytomegalovirus, Epstein-Barr virus, rubella virus, and human immunodeficiency virus were negative. IgM positivity indicated recent infection with COVID-19 in these series and could confirm the causal relationship.
We believe physicians should be aware of possible different clinical manifestations and complications related to COVID-19 infection. Early screening and diagnosis of COVID-19 infection result in the prevention of further transmission.
Statement of Ethics
The research was carried out according to the principles of the Declaration of Helsinki. Subjects (or their parents or guardians) have given their written informed consent. The local Ethics Review Committee of Tehran University of Medical Science approved the study protocol. Approval ID is IR.TUMS.AMIRALAM.REC.1399.006.
Conflict of Interest Statement
The authors have no conflicts of interest to declare.
Funding Sources
The authors did not receive any funding.
Author Contributions
Saeed Sohrabpour: collecting data. Farrokh Heidari: writing of the article. Ebrahim Karimi: collecting data. Reza Ansari: collecting data. Firouzeh Heidari: writing and editing of the article. Ardavan Tajdini: Editing of the article.
Footnotes
verified
References
- 1↑
Patel A , Jernigan DB. Initial public Health response and interim clinical guidance for the 2019 novel coronavirus outbreak: United States, December 31, 2019–February 4, 2020. MMWR Morb Mortal Wkly Rep. 2020 Feb 7;69(5):140–6.
- 2↑
Agrawal S , Goel AD, Gupta N. Emerging prophylaxis strategies against COVID-19. Monaldi Arch Chest Dis. 2020 Mar 30;90(1).
- 3↑
Sun P , Qie S, Liu Z, Ren J, Xi J. Clinical characteristics of 5732 patients with 2019-nCoV infection. 2020. Available at SSRN 3539664.http://dx.doi.org/10.2139/ssrn.3539664
- 4↑
Ansari R , Gheitani M, Heidari F, Heidari F. Oral cavity lesions as a manifestation of the novel virus (COVID‐19): a letter‐to‐editor. Oral Diseases. 2020. http://dx.doi.org/10.1111/odi.13465.
- 5
Heidari F , Karimi E, Firouzifar M, Khamushian P, Ansari R, Mohammadi Ardehali M, et al.. Anosmia as a prominent symptom of COVID-19 infection. Rhin. 2020;58(3):302–3.http://dx.doi.org/10.4193/rhin20.140.
- 6↑
Recalcati S . Cutaneous manifestations in COVID‐19: a first perspective. J Eur Acad Dermatol Venereol. 2020 May;34(5):e212–13.
- 7↑
Muller I , Cannavaro D, Dazzi D, Covelli D, Mantovani G, Muscatello A, et al.. SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol. 2020 Sep;8(9):739–41.
- 8↑
Desailloud R , Hober D. Viruses and thyroiditis: an update. Virol J. 2009;6(1):5.http://dx.doi.org/10.1186/1743-422X-6-5.
- 9↑
Kalkan EA , Ates I. A case of subacute thyroiditis associated with Covid-19 infection. J Endocrinol Invest. 2020 Jun 5:1–2.
- 10
Bellastella G , Maiorino M, Esposito K. Endocrine complications of COVID-19: what happens to the thyroid and adrenal glands? J Endocrinol Invest. 2020 Aug;43(8):1169–70.
- 11
Brancatella A , Ricci D, Viola N, Sgrò D, Santini F, Latrofa F. Subacute thyroiditis after SARS-CoV-2 infection. J Clin Endocrinol Metab. 2020;105(7):dgaa276.
- 12↑
Ippolito S , Dentali F, Tanda M. SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report. J Endocrinol Invest. 2020 Jun 2:1–2.
- 13↑
Nishihara E , Ohye H, Amino N, Takata K, Arishima T, Kudo T, et al.. Clinical characteristics of 852 patients with subacute thyroiditis before treatment. Intern Med. 2008;47(8):725–9.http://dx.doi.org/10.2169/internalmedicine.47.0740.
